Objective: To evaluate the efficacy and safety of amniopatch in pregnancies 
associated with spontaneous preterm premature rupture of fetal membranes 
(PPROM).Methods: A randomized controlled trial that involved 100 women diagnosed 
with PPROM between 24 and 34 weeks of gestational age. Participants were 
randomized equally into two groups. Group I in which amniopatch was done in 
addition to the routine management. Group II was treated with routine management 
including antibiotics and corticosteroids.Results: Amniopatch was successful in 
complete sealing of the membrane defect in 6/50 (12%) of women while none the 
control group have undergone similar sealing (p = .0144, RR = 0.88). Women in 
the amniopatch group showed a significant increase of AFI compared to controls 
(12 versus 0, p = .0001, RR = 0.56).Conclusion: The amniopatch procedure is a 
successful technique that safely enhances sealing of fetal membranes and restore 
the AFI.Clinical trial registration: NCT03473210SynopsisThe amniopatch procedure 
is a successful technique that could be done safely to enhance sealing the fetal 
membranes and restoring the AFI after PPROM.